PCDHB16 Inhibitors
Inhibitors of PCDHB16 function by interfering with a variety of signaling pathways and cellular processes that are crucial for the protein's role in cell-cell interactions and adhesion. For instance, certain tyrosine kinase inhibitors can disrupt cell signaling that intersects with PCDHB16-mediated adhesion, resulting in a reduction in cellular proliferation which is closely tied to the protein's function. These inhibitors target pathways like EGFR and Src/Abl, which are involved in the regulation of cell shape, motility, and cytoskeletal dynamics, all of which are important for the proper function of PCDHB16 in maintaining cellular architecture and communication. By altering these pathways, the inhibitors may decrease PCDHB16's influence in the complex network of cellular interactions.
Other inhibitors act on the PI3K/AKT and MAPK/ERK pathways, which are implicated in cellular survival, growth, and differentiation processes that PCDHB16 may be involved in. Compounds such as PI3K inhibitors and MEK inhibitors lead to a suppression of these pathways, potentially attenuating the function of PCDHB16 in these cellular mechanisms. Additionally, inhibitors of gamma-secretase prevent the proteolytic cleavage of membrane proteins, which could impact PCDHB16's role in cell signaling and adhesion. Similarly, CDK4/6 inhibitors halt cell cycle progression, indirectly affecting PCDHB16's associated signaling pathways and its role in cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
An EGFR tyrosine kinase inhibitor that can disrupt downstream signaling pathways which may intersect with PCDHB16-mediated cell adhesion processes, leading to reduced cellular proliferation and potential inhibition of PCDHB16 function in cell-cell interactions. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A phosphoinositide 3-kinase (PI3K) inhibitor that halts the PI3K/AKT pathway, potentially diminishing PCDHB16's role in cellular survival and growth processes by affecting the intracellular signaling that supports these functions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor which suppresses the PI3K/AKT pathway, possibly attenuating PCDHB16's involvement in cellular mechanisms related to survival, growth, and adhesion. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
A gamma-secretase inhibitor that can prevent proteolytic cleavage of membrane proteins, potentially affecting PCDHB16-mediated cell signaling and adhesion by altering its cleavage and thereby its function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor that blocks the MAPK/ERK pathway, which may indirectly lead to inhibition of PCDHB16 by altering intracellular signaling required for proper PCDHB16-mediated cell adhesion and communication. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that might reduce PCDHB16 activity by interfering with stress response pathways and cytokine signaling that could indirectly impact PCDHB16's role in cellular processes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK) that can modulate cellular apoptosis and differentiation, possibly affecting PCDHB16 function by altering the cellular context in which PCDHB16 operates. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A selective inhibitor of MEK1/2 that can impede the MAPK/ERK signaling pathway, potentially decreasing PCDHB16’s influence in cellular growth and differentiation mechanisms where it might be involved. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A broad-spectrum tyrosine kinase inhibitor that could disrupt signal transduction pathways affecting cell shape and motility, which may in turn influence PCDHB16's role in cellular adhesion and signaling. | ||||||
Neratinib | 698387-09-6 | sc-364549 sc-364549A sc-364549B sc-364549C sc-364549D | 5 mg 25 mg 100 mg 500 mg 1 g | $92.00 $214.00 $383.00 $755.00 $1250.00 | 4 | |
An irreversible inhibitor of HER2 and EGFR kinases that can block signaling pathways involved in cellular growth and differentiation, potentially altering PCDHB16's function in cell-cell adhesion and signaling. | ||||||